In this episode, Chad dive into the news that's sending shockwaves throughout the United States - the recommendation for Cannabis to move from Schedule 1 to Schedule 3.

Join as he engages in a thought-provoking conversation with FoxNrth Strategist and Regulatory Expert, Chris Murray. Together, they unravel the intricacies of this monumental shift and provide you with an informative, visually engaging presentation that answers all the key questions you've been itching to ask.

You will learn about,
1. What does this rescheduling mean for patients seeking cannabis-based treatments?
2. How will prescribers adapt to these changes in regulations?
3. What impact will this have on Multi-State Operators (MSOs) in the cannabis industry?
4. And, what does it mean for pharmaceutical companies moving forward?
5. Relevance to UN Single Convention.

Ver todos los episodios